GLPBio

Immunology/Inflammation

Read More about this category

The immune and inflammation-related pathway including the Toll-like receptors pathway, the B cell receptor signaling pathway, the T cell receptor signaling pathway, etc.

Toll-like receptors (TLRs) play a central role in host cell recognition and responses to microbial pathogens. TLR4 initially recruits TIRAP and MyD88. MyD88 then recruits IRAKs, TRAF6, and the TAK1 complex, leading to early-stage activation of NF-κB and MAP kinases [1]. TLR4 is endocytosed and delivered to intracellular vesicles and forms a complex with TRAM and TRIF, which then recruits TRAF3 and the protein kinases TBK1 and IKKi. TBK1 and IKKi catalyze the phosphorylation of IRF3, leading to the expression of type I IFN [2].

BCR signaling is initiated through ligation of mIg under conditions that induce phosphorylation of the ITAMs in CD79, leading to the activation of Syk. Once Syk is activated, the BCR signal is transmitted via a series of proteins associated with the adaptor protein B-cell linker (Blnk, SLP-65). Blnk binds CD79a via non-ITAM tyrosines and is phosphorylated by Syk. Phospho-Blnk acts as a scaffold for the assembly of the other components, including Bruton’s tyrosine kinase (Btk), Vav 1, and phospholipase C-gamma 2 (PLCγ2) [3]. Following the assembly of the BCR-signalosome, GRB2 binds and activates the Ras-guanine exchange factor SOS, which in turn activates the small GTPase RAS. The original RAS signal is transmitted and amplified through the mitogen-activated protein kinase (MAPK) pathway, which including the serine/threonine-specific protein kinase RAF followed by MEK and extracellular signal related kinases ERK 1 and 2 [4]. After stimulation of BCR, CD19 is phosphorylated by Lyn. Phosphorylated CD19 activates PI3K by binding to the p85 subunit of PI3K and produce phosphatidylinositol-3,4,5-trisphosphate (PIP3) from PIP2, and PIP3 transmits signals downstream [5].

Central process of T cells responding to specific antigens is the binding of the T-cell receptor (TCR) to specific peptides bound to the major histocompatibility complex which expressed on antigen-presenting cells (APCs). Once TCR connected with its ligand, the ζ-chain–associated protein kinase 70 molecules (Zap-70) are recruited to the TCR-CD3 site and activated, resulting in an initiation of several signaling cascades. Once stimulation, Zap-70 forms complexes with several molecules including SLP-76; and a sequential protein kinase cascade is initiated, consisting of MAP kinase kinase kinase (MAP3K), MAP kinase kinase (MAPKK), and MAP kinase (MAPK) [6]. Two MAPK kinases, MKK4 and MKK7, have been reported to be the primary activators of JNK. MKK3, MKK4, and MKK6 are activators of P38 MAP kinase [7]. MAP kinase pathways are major pathways induced by TCR stimulation, and they play a key role in T-cell responses.

Phosphoinositide 3-kinase (PI3K) binds to the cytosolic domain of CD28, leading to conversion of PIP2 to PIP3, activation of PKB (Akt) and phosphoinositide-dependent kinase 1 (PDK1), and subsequent signaling transduction [8].

 

References

[1] Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors[J]. Nature immunology, 2010, 11(5): 373-384.

[2] Kawai T, Akira S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011, 34(5): 637-650.

[3] Packard T A, Cambier J C. B lymphocyte antigen receptor signaling: initiation, amplification, and regulation[J]. F1000Prime Rep, 2013, 5(40.10): 12703.

[4] Zhong Y, Byrd J C, Dubovsky J A. The B-cell receptor pathway: a critical component of healthy and malignant immune biology[C]//Seminars in hematology. WB Saunders, 2014, 51(3): 206-218.

[5] Baba Y, Matsumoto M, Kurosaki T. Calcium signaling in B cells: regulation of cytosolic Ca 2+ increase and its sensor molecules, STIM1 and STIM2[J]. Molecular immunology, 2014, 62(2): 339-343.

[6] Adachi K, Davis M M. T-cell receptor ligation induces distinct signaling pathways in naive vs. antigen-experienced T cells[J]. Proceedings of the National Academy of Sciences, 2011, 108(4): 1549-1554.

[7] Rincón M, Flavell R A, Davis R A. The Jnk and P38 MAP kinase signaling pathways in T cell–mediated immune responses[J]. Free Radical Biology and Medicine, 2000, 28(9): 1328-1337.

[8] Bashour K T, Gondarenko A, Chen H, et al. CD28 and CD3 have complementary roles in T-cell traction forces[J]. Proceedings of the National Academy of Sciences, 2014, 111(6): 2241-2246.

Research Areas

Products Related to Immunology/Inflammation(4745)

  • GC78932 structure
    GC78932MINA53-IN-1
    CAS: 2863676-85-9
    Purity: >99.50%

    MINA53-IN-1 is a selective MINA53 inhibitor with an IC 50 of 1.5 μM.

  • GC78933 structure
    GC78933DB1055
    CAS: 869767-86-2
    Purity: >99.50%

    DB1055 is a HOXA9 inhibitor that competes with HOXA9 binding to DNA (blocking its DNA interaction activity).

  • GC78934 structure
    GC78934CT 32228
    CAS: 521064-34-6
    Purity: >95.00%

    CT 32228 is an inhibitor of lysophosphatidic acid acyltransferase-β ( LPAAT-β ).

  • GC78935 structure
    GC78935Flucofuron
    CAS: 370-50-3
    Purity: >99.50%

    Flucofuron exhibits high efficacy against trophozoites of both N.

  • GC78936 structure
    GC78936(S)-Edelfosine
    CAS: 83542-43-2
    Purity: >99.50%

    (S)-Edelfosine ((S)-ET-18-OCH3) is the (S)-enantiomer of Edelfosine (ET-18-OCH3).

  • GC78937 structure
    GC78937(1S)-PMMB276
    Purity: >98.00%

    (1S)-PMMB276 is the (1S)-enantiomer of PMMB276.

  • GC78938 structure
    GC78938HF-125
    Purity: >99.50%

    HF-125 is an orally active, highly selective small-molecule inhibitor of Tribbles 2 (TRIB2).

  • GC78939 structure
    GC78939TMLZ-G46
    CAS: 3116767-83-7
    Purity: >98.00%

    TMLZ-G46 is an orally active ZNF207 inhibitor with blood-brain barrier penetration ability, with a K d value of 68 nM.

  • GC78940 structure
    GC78940DD-CIP2
    Purity: >99.50%

    DD-CIP2 is a DNA damage and apoptosis inducer.

  • GC78941 structure
    GC78941KLA peptide acetate
    Purity: >99.50%

    KLA peptide acetate is a naturally occurring Antibiotic peptide that is nontoxic outside of cells but is toxic when it enters into the interior of targeted cells.

  • GC78943 structure
    GC78943Corisin
    CAS: 2651277-02-8
    Purity: >99.00%

    Corisin is a pro-apoptotic small peptide produced by Staphylococcus species.

  • GC78944 structure
    GC789442',4-Dihydroxychalcone
    CAS: 13323-66-5
    Purity: >98.00%

    2',4-Dihydroxychalcone is an orally active natural chalcone flavonoid.

  • GC78945 structure
    GC78945Bid BH3 peptide acetate
    Purity: >98.00%

    Bid BH3 peptide acetate is a pro- apoptotic peptide derived from the Bid protein.

  • GC78947 structure
    GC78947FS1 peptide
    Purity: >98.50%

    FS1 peptide is a synthetic BH3 mimetic peptide that shows potential in enhancing NK cell-mediated cancer immunity.

  • GC78950 structure
    GC789504′-O-Methylglabridin
    CAS: 68978-09-6
    Purity: >98.50%

    4′-O-Methylglabridin is an apoptosis inducer with antioxidant, cell cycle-disrupting and anticancer cytotoxic activities.

  • GC78952 structure
    GC78952d-(KLAKLAK)2, Proapoptotic Peptide acetate
    Purity: >98.00%

    d-(KLAKLAK) 2, Proapoptotic Peptide acetate is a pro- Apoptotic peptide whose core mechanism of action is to disrupt organelle membranes, especially mitochondrial membranes, thereby inducing apoptosis.

  • GC78953 structure
    GC78953Haplophytin-A
    CAS: 366477-44-3
    Purity: >98.00%

    Haplophytin-A is a quinoline alkaloid.

  • GC78954 structure
    GC78954OH14
    CAS: 1018153-87-1
    Purity: >99.50%

    OH14 is a cellular FLICE-like inhibitory protein ( cFLIP) inhibitor and TNF-related apoptosis-inducing ligand ( TRAIL ) sensitizer.

  • GC78955 structure
    GC78955AP21998
    CAS: 292606-90-7
    Purity: >99.00%

    AP21998 is a non-immunosuppressive derivative of Rapamycin and an inducer of exocytosis.

  • GC78957 structure
    GC78957(2S,3R,4S)-ASX-173
    CAS: 2748800-07-7
    Purity: >99.00%

    (2S,3R,4S)-ASX-173 is the (2S,3R,4S)-enantiomer of ASX-173.

  • GC78958 structure
    GC78958TMLB-C16
    CAS: 2923531-50-2
    Purity: >99.00%

    TMLB-C16 is a potent and orally active B3GAT3 inhibitor with a K D of 3.962 μM.

  • GC78960 structure
    GC78960DL78
    CAS: 132993-79-4
    Purity: >99.00%

    DL78 is an effective anti-mitotic agent.

  • GC78961 structure
    GC78961GPS167
    CAS: 3034312-19-8
    Purity: >98.00%

    GPS167 is a CLK kinase inhibitor that potently and selectively inhibits recombinant human CLK1, CLK2 and CLK4.

  • GC78962 structure
    GC78962MS1129
    Purity: >98.00%

    MS1129 is a DNMT degrader that induces proteasomal degradation of DNMT1, DNMT3A and DNMT3B proteins.